70 Participants Needed

Endosphenoidal Coil Placement for Pituitary Tumors

GC
MX
PC
Overseen ByPrashant Chittiboina, M.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

How does the Endosphenoidal Coil Placement treatment for pituitary tumors differ from other treatments?

Endosphenoidal Coil Placement is unique because it involves placing coils directly into the blood vessels near the pituitary tumor, which is different from traditional surgical or radiation treatments. This method is similar to endovascular coiling used for aneurysms, where coils are inserted to block blood flow to the target area, potentially reducing the tumor's blood supply and size.12345

What is the purpose of this trial?

Background:Pituitary tumors can cause problems by secreting hormones in the body. They can also problems by growing large and pushing on organs near the pituitary gland. The best treatment for such tumors is to remove them by surgery. But that may be sometimes difficult. Some tumors maybe too small to see. Some other tumors maybe so large that portions maybe left behind during surgery. The endosphenoidal coil (ESC) is a new magnetic resonance imaging (MRI) device. It fits in a small space made during surgery near the pituitary. Researchers want to see if it helps transmit MRI signals during surgery to make better images of the pituitary gland and tumors.Objective:To test the safety of using a new coil device to improve MRI imaging of pituitary tumors during surgery.Eligibility:Adults 18-85 years old who are having pituitary tumor surgery at NIHDesign:Participants will be screened with:* Medical history* Physical exam* Review of prior brain scans* Blood and pregnancy testsAll participants will have MRI of pituitary gland. They will lie on a table that slides into a metal cylinder in a strong magnetic field. They will lie still and get earplugs for loud sounds. A dye will be inserted into an arm vein by needle.Participants will stay in the hospital for about 1 week. They will repeat screening tests.Participants will have standard pituitary surgery. They will get medicine to go to sleep. The surgeon will create a path to the pituitary gland from under the lip.During surgery, the ESC will be placed through the path to near the pituitary. Then an MRI will be done during surgery.Then the ESC will be removed and standard surgery will continue.Participants will get standard post-operative care under another protocol.

Research Team

PC

Prashant Chittiboina, M.D.

Principal Investigator

National Institute of Neurological Disorders and Stroke (NINDS)

Eligibility Criteria

Adults aged 18-85 scheduled for pituitary tumor surgery at NIH can join. They must be able to consent and fit on the MRI table, without contraindications to MRI or its contrast agent. Pregnant or nursing individuals, those with variant anatomy posing risks, or over 85 are excluded.

Inclusion Criteria

I am an adult with a pituitary gland tumor needing surgery.
NIH employees are included in the study
Enrolled in 03-N-0164, Evaluation and Treatment of Neurosurgical Disorders. If not enrolled, subjects will not be able to be included in the study as clinical and research procedures are done under the 03-N-0164 protocol.
See 1 more

Exclusion Criteria

Are pregnant or nursing
You are too big or heavy to fit on the MRI table during surgery. Being scared of tight spaces is not a reason to be excluded from the study.
Have an absolute contraindication to MRI imaging or MRI contrast agent according to Rad&IS screening including devices or conditions.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants undergo standard transsphenoidal surgery with the placement of the endosphenoidal coil for MRI imaging during surgery

1 week
In-hospital stay

Follow-up

Participants receive standard post-operative care and are monitored for safety and effectiveness of the procedure

4 weeks
2 visits (in-person)

Treatment Details

Interventions

  • Endosphenoidal Coil
Trial Overview The trial is testing a new device called an endosphenoidal coil (ESC) during transsphenoidal surgery. The ESC aims to improve MRI images of the pituitary gland and tumors in real-time during the operation.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
ENDOSPHENOIDAL COIL

Find a Clinic Near You

Who Is Running the Clinical Trial?

National Institute of Neurological Disorders and Stroke (NINDS)

Lead Sponsor

Trials
1,403
Recruited
655,000+

Findings from Research

A 62-year-old female underwent a successful stent-assisted coiling procedure for an 11-mm complex aneurysm without any complications, indicating the safety of this intervention.
The procedure involved careful coiling of both lobes of the aneurysm, with follow-up planned to assess any residual filling, demonstrating the efficacy of the technique in managing complex aneurysms.
Endovascular treatment of a complex bilobed left superior hypophyseal internal carotid artery aneurysm: a case illustration.Hamade, YJ., El Tecle, NE., Zammar, SG., et al.[2014]
The EDC-10 infini coil demonstrated excellent conformability and safety in embolizing cavernous sinus dural arteriovenous fistulas (DAVFs) in six patients, with no cases of permanent cranial nerve palsy reported.
While two patients experienced transient abducens palsy post-operation, they both fully recovered, indicating that the EDC-10 infini coil is a safe option for this complex procedure.
Efficacy of a unique straight, conformable, bare platinum coil in the treatment of cavernous sinus dural arteriovenous fistula.Harada, K., Kakumoto, K.[2018]
In a study involving 20 patients, endovascular embolization using liquid coils was performed successfully in 22 procedures, achieving complete obliteration of target vessels without any complications.
Liquid coils proved to be a safe and effective embolic material, facilitating subsequent surgical resections of embolized lesions in 14 cases and radiosurgery in 2 cases, although some large vessels required additional embolic materials for complete occlusion.
Transarterial embolization of cerebrospinal lesions with liquid coils.Hara, Y., Nakamura, M., Ehara, K., et al.[2017]

References

Endovascular treatment of a complex bilobed left superior hypophyseal internal carotid artery aneurysm: a case illustration. [2014]
Efficacy of a unique straight, conformable, bare platinum coil in the treatment of cavernous sinus dural arteriovenous fistula. [2018]
Transarterial embolization of cerebrospinal lesions with liquid coils. [2017]
Double microcatheter technique for coil embolization of small aneurysms with unfavorable configurations: A comparative study of the aneurysms that are ≤3 mm or >3 mm. [2018]
Navigation of Stents across Communicating Arteries for Aneurysm Embolization. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security